Key result
Achieving blood pressure control after 3 months of treatment was associated with a greater decrease in plasma BNP levels compared to poor control.
Why the study?
Does antihypertensive treatment and subsequent blood pressure control reduce plasma BNP levels in patients with newly diagnosed essential hypertension?
Cohort (n=186)
Does antihypertensive treatment and subsequent blood pressure control reduce plasma BNP levels in patients with newly diagnosed essential hypertension?
Plasma BNP levels correlate with systolic blood pressure and decrease significantly upon achieving blood pressure control, suggesting its potential as a biomarker for effective hypertension management.
Answers are grounded in this paper and cite their sources.
May support BNP as a treatment-response marker in hypertension; hypothesis-generating and requires prospective validation before clinical use.
OBJECTIVE: To investigate plasma brain natriuretic peptide (BNP) concentrations in association with blood pressure (BP) at baseline and after antihypertensive drug treatment. PATIENTS AND METHODS: We prospectively examined 186 individuals with newly diagnosed essential hypertension without target organ damage, whose mean age was 48.7 +/- 10.9 years. Treatment initiation began with irbesartan 150 mg/day and was doubled at 4 weeks in cases of inadequate BP control. If indicated, at 8-week-follow-up hydrochlorothiazide 12.5 mg alone or with amlodipine 5-10 mg was added. BNP levels were measured at baseline and after 3 months of antihypertensive treatment. RESULTS: At baseline plasma BNP levels were found to be related to systolic BP (r = 0.27, P < 0.001), independent of age, sex, smoking status, BMI and left ventricular mass index estimated by echocardiography (beta = 11.81, SE = 3.82, P = 0.002). Additionally, higher BNP concentrations were observed in patients with stage 2 hypertension compared with those with stage 1 (median 38.9 vs. 29.9 pg/ml, P = 0.022). Multivariate analysis showed a positive association between BNP and systolic BP variability (beta = 0.03, SE = 0.01, P = 0.034). At follow-up, 64.7% of the participants who had achieved BP control showed decreased BNP levels in contrast to those with poor BP control (median change -14.5 vs. -1.3 and median range from -34.4 to -4.4 vs. -9.6 to 10.9, respectively, P < 0.001). CONCLUSION: In this hypertensive population, increased BNP concentrations are associated with higher BP levels and systolic BP variability. The fall of BNP observed in those who achieved BP control indicates that BNP could be used as a biochemical marker of effective BP control and target organ protection.
No takes yet. Share an insight, caveat, or question.
Andreadis et al. (2009) conducted a cohort in newly diagnosed essential hypertension (n=186). Achieved blood pressure control vs. Poor blood pressure control was evaluated on Change in plasma BNP levels (p=<0.001). Achieving blood pressure control after 3 months of treatment was associated with a greater decrease in plasma BNP levels compared to poor control.
Synapse has enriched 10 related papers. Consider them for comparative context: